Carret Asset Management LLC Has $3.37 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Carret Asset Management LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,095 shares of the company’s stock after acquiring an additional 190 shares during the period. Carret Asset Management LLC’s holdings in HCA Healthcare were worth $3,367,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Norges Bank acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $694,985,000. Royal Bank of Canada increased its position in shares of HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after acquiring an additional 1,183,890 shares in the last quarter. Capital World Investors raised its stake in shares of HCA Healthcare by 112.1% in the fourth quarter. Capital World Investors now owns 1,772,627 shares of the company’s stock worth $479,815,000 after purchasing an additional 936,823 shares during the last quarter. Sanders Capital LLC lifted its stake in HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares in the last quarter. Finally, TD Asset Management Inc raised its holdings in shares of HCA Healthcare by 230.5% in the fourth quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock valued at $149,747,000 after purchasing an additional 385,854 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,863 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the sale, the senior vice president now owns 19,612 shares in the company, valued at approximately $6,397,042.16. The disclosure for this sale can be found here. Insiders have sold a total of 12,397 shares of company stock worth $3,921,929 in the last ninety days. 1.70% of the stock is owned by insiders.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. Barclays lifted their price target on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research note on Thursday, May 30th. TD Cowen decreased their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a report on Tuesday, April 30th. Oppenheimer upped their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research note on Monday, April 29th. Finally, Robert W. Baird initiated coverage on HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target for the company. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $326.53.

HCA Healthcare Price Performance

NYSE:HCA traded up $6.85 during midday trading on Wednesday, hitting $326.55. The company had a trading volume of 944,812 shares, compared to its average volume of 1,102,447. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The stock’s fifty day moving average price is $326.06 and its 200-day moving average price is $318.07. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $344.20. The company has a market capitalization of $85.53 billion, a PE ratio of 16.12, a P/E/G ratio of 1.49 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.93 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were issued a $0.66 dividend. The ex-dividend date was Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.81%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.